Showing posts with label Therapy. Show all posts
Showing posts with label Therapy. Show all posts

Monday, 20 March 2017

Lifecycle Analysis Of Global Oxygen Therapy Devices Market by Application, Product Type And End User, 2017 - 2021

ResearchMoz presents this most up-to-date research on "Lifecycle Analysis Of Global Oxygen Therapy Devices Market by Application, Product Type And End User, 2017 - 2021".

Oxygen therapy devices are an integral part of respiratory disease management and other diverse therapy areas. The global oxygen therapy devices market has been witnessing continuous technological innovations and developments over the years. The global oxygen therapy devices market is growing at a steady rate.

Technavios analysts forecast the global oxygen therapy devices market to grow at a CAGR of 10.16% during the period 2017-2021.

Covered in this report 
The report covers the present scenario and the growth prospects of the global oxygen therapy devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various oxygen therapy devices and consumables to key end-users such as hospitals, clinics, and homecare.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Oxygen Therapy Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
Chart Industries
DeVilbiss Healthcare
Fisher & Paykel Healthcare
Invacare
Philips Respironics

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1027695

Other prominent vendors 
3B Medical
Airing
Allied Healthcare Products
Apnex Medical
CareFusion (BD)
GCE Healthcare
GE Healthcare
Inogen


Market driver 
Increasing prevalence of respiratory disorders.
For a full, detailed list, view our report 

Market challenge 
Growing end-user preference towards refurbished equipment.
For a full, detailed list, view our report 

Market trend 
Increased adoption of portable systems.
For a full, detailed list, view our report 

Key questions answered in this report 
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors? 

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1027695

Thursday, 23 February 2017

Growing Popularity Of Gene Therapy Global Market - Key Trends, Analysis, Size, Volume, Share, Growth and Forecast 2017 - 2019

ResearchMoz presents this most up-to-date research on "Growing Popularity Of Gene Therapy Global Market - Key Trends, Analysis, Size, Volume, Share, Growth and Forecast 2017 - 2019".

Gene therapy involves use of DNA as a pharmaceutical agent to treat diseases. It is one of the most important developments in the field of medicine that has potential to treat various lethal diseases such as HIV, cancer and cystic fibrosis. In the long run, biotechnology and clinical trial industries will benefit from developments in gene therapy and provide potential treatment solutions for various incurable diseases. 

In the present scenario, various pharmaceutical companies are using clinical data to validate the concept of gene therapy. Moreover, many venture capital investors are also showing their interest in gene therapy, and are investing heavily in its development. However, gene therapy is highly dependent on the regulatory approvals and most of the products are currently in clinical trial phase. Most of these gene therapy products are for cancer and cardiovascular diseases, and are in Phase III/ Phase II of clinical trials.

In addition, growing popularity of DNA vaccines boost advances in gene therapy and is likely to be practiced in clinics in the near future, with a number of therapy programs now in phase II/III trials, showing promising results.

Some of the major players operating in the market are AnGes MG, BioSante Pharmaceuticals, GenVec, Genzyme Corporation, Oxford BioMedica, Transgene, Urigen Pharmaceuticals and Vical.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=190531

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments 

Thursday, 16 February 2017

Oxygen Ventilation Therapy Industry By Material, Application, and Geography Global Forecast to 2021

ResearchMoz presents this most up-to-date research on "Oxygen Ventilation Therapy Industry By Material, Application, and Geography Global Forecast to 2021".

Oxygen Ventilation Therapy Report by Material, Application, and Geography Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).

The report firstly introduced the Oxygen Ventilation Therapy basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with: 
1.) basic information; 
2.) the Asia Oxygen Ventilation Therapy Market; 
3.) the North American Oxygen Ventilation Therapy Market; 
4.) the European Oxygen Ventilation Therapy Market; 
5.) market entry and investment feasibility;
6.) the report conclusion.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=970709

Table of Contents

Part I Oxygen Ventilation Therapy Industry Overview

Chapter One Oxygen Ventilation Therapy Industry Overview
1.1 Oxygen Ventilation Therapy Definition
1.2 Oxygen Ventilation Therapy Classification Analysis
1.2.1 Oxygen Ventilation Therapy Main Classification Analysis
1.2.2 Oxygen Ventilation Therapy Main Classification Share Analysis
1.3 Oxygen Ventilation Therapy Application Analysis
1.3.1 Oxygen Ventilation Therapy Main Application Analysis
1.3.2 Oxygen Ventilation Therapy Main Application Share Analysis
1.4 Oxygen Ventilation Therapy Industry Chain Structure Analysis
1.5 Oxygen Ventilation Therapy Industry Development Overview
1.5.1 Oxygen Ventilation Therapy Product History Development Overview
1.5.1 Oxygen Ventilation Therapy Product Market Development Overview

Chapter Two Oxygen Ventilation Therapy Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis 
2.1.1 Upstream Raw Materials Price Analysis 
2.1.2 Upstream Raw Materials Market Analysis
2.1.3 Upstream Raw Materials Market Trend
2.2 Down Stream Market Analysis
2.1.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=970709

Tuesday, 24 January 2017

Oxygen Therapy Devices Market In North America During The Forecast Period 2017 - 2023

Researchmoz added Most up-to-date research on "Oxygen Therapy Devices Market In North America During The Forecast Period 2017 - 2023" to its huge collection of research reports.
This report on the North America oxygen therapy devices market studies the current and future prospects of the market. North America oxygen therapy devices market is segmented on the basis of products and application. On the basis of products the oxygen therapy devices market is segmented into oxygen source equipment and oxygen delivery devices. Rise in COPD and asthma cases and significant technological advancements in the field of respiratory devices have triggered the growth of the oxygen therapy devices market. Additionally, high risk of lung damage due to tobacco consumption, pollution, and occupational hazards across the globe is anticipated to augment the market during the forecast period. Moreover, easy-to-use and portable devices are likely to boost the growth of the market.
The North America oxygen therapy devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the North America oxygen therapy devices market with respect to market segments based on the product type, application and geographic analysis.
Based on product type, the North America oxygen therapy devices market has been segmented into two major categories: oxygen source equipment and oxygen delivery devices. The oxygen source equipment segment is further categorized into oxygen cylinders, oxygen concentrators and liquid oxygen devices. Moreover, the oxygen delivery devices segment has been sub-segmented into simple oxygen mask, nasal cannula, Venturi mask, non-rebreather mask, bag valve mask, and CPAP mask.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=667882
Table of Content
1. Preface
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
2. Executive Summary
2.1. North America Oxygen Therapy Devices: Market Snapshot
2.2. North America Oxygen Therapy Devices Market Share, by Application, 2014 (US$ Mn)
2.3. North America Oxygen Therapy Devices Market Share, by Product Type, 2014 (US$ Mn)
3. Industry Analysis : North America Oxygen Therapy Devices
3.1. Introduction and Market Definition
3.2. Drivers
3.2.1. Rise in incidence of COPD and other respiratory diseases
3.2.2. Increasing patient preference for portable home oxygen therapy equipment
3.3. Restraints
3.3.1. Patient concerns associated with complication of long-term oxygen therapy
3.4. Opportunities
3.4.1. Technological advancements in the field of respiratory care to spur market growth
3.4.2. Increasing government initiatives toward improving respiratory care

Thursday, 12 January 2017

2017 - 2022: Injectable Targeted Therapy Global Market

Researchmoz added Most up-to-date research on "2017 - 2022: Injectable Targeted Therapy Global Market" to its huge collection of research reports.

Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of drug’s side-effects and reduced oscillation in circulating drug levels. The most important characteristics of targeted drug delivery system are non-toxic, non-immunogenic, both physically and chemically stable in-vivo and in-vitro and controllable and predictable rate of drug release. The various types of delivery vehicles used in injectable targeted therapy are liposomes, micelles, dendrimers, biodegradable particles and artificial DNA nanostructures. The applications of injectable targeted therapy are widely classified such as cardiovascular diseases, respiratory diseases and diabetes, but the primary application of injectable targeted therapy is in oncology. The injectable drugs primary target range included oncology, hormonal imbalances, autoimmune diseases, orphan/rare diseases (Cystic Fibrosis, Ribose-5-phosphate isomerase deficiency or RPI deficiency, Hemophilia and Wilson\'s disease) and others (allergies, aesthetic treatment hepatitis C and pain management).

The major drivers of injectable targeted therapy market are growing prevalence of senile disorders, sedentary lifestyle and increasing prevalence of cancer. According to World Health Organization (WHO), there were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 worldwide. While in same year 57% (8 million) of new cancer cases, 65% (5.3 million) of the cancer deaths and 48% (15.6 million) of the 5-year prevalent cancer cases occurred in the less developed regions from African and Asian continent. The prevalence of cancer is expected to increase and predicted to reach 24 million by 2035.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=214119

This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments

Tuesday, 10 January 2017

Growth Prospects Of Global Testosterone Replacement Therapy Market For 2017-2020

Researchmoz added Most up-to-date research on "Growth Prospects Of Global Testosterone Replacement Therapy Market For 2017-2020" to its huge collection of research reports.

Testosterone replacement therapy, also called androgen replacement therapy, is typically used to treat hypogonadism. Testosterone, a hormone produced by the testes, is responsible for the development of secondary sexual characters in men. The levels of testosterone decrease gradually with age, but sometimes this decline is seen even in young men, leading to a condition known as hypogonadism. This can be treated with external supply of testosterone in the form of gels, patches, injectable, or oral drugs.

Technavios analysts forecast the global testosterone replacement therapy market is gradually declining and will post a CAGR of (3.35) % during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the global testosterone replacement therapy market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs that treat and prevent hypogonadism.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Testosterone Replacement Therapy Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=775689

Key vendors 
AbbVie
Allergan
Eli Lilly and Company
Endo Pharmaceuticals

Other prominent vendors
Acerus Pharmaceuticals Corporation
Antares Pharma
Bayer HealthCare Pharmaceuticals 
Bedford Labs
Clarus Therapeutics
Ferring Pharmaceuticals
Forendo Pharma 
Juniper Pharmaceuticals 
Lipocine
MetP Pharma

Market driver 
Increase in older population
For a full, detailed list, view our report 

Market challenge 
FDA warnings on use of testosterone products
For a full, detailed list, view our report 

Market trend 
Entry of SARMs
For a full, detailed list, view our report 

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors? 

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=775689

Sunday, 8 January 2017

Oxygen Therapy Devices Market - North America Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023

ResearchMoz presents this most up-to-date research on "Oxygen Therapy Devices Market - North America Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023".
This report on the North America oxygen therapy devices market studies the current and future prospects of the market. North America oxygen therapy devices market is segmented on the basis of products and application. On the basis of products the oxygen therapy devices market is segmented into oxygen source equipment and oxygen delivery devices. Rise in COPD and asthma cases and significant technological advancements in the field of respiratory devices have triggered the growth of the oxygen therapy devices market. Additionally, high risk of lung damage due to tobacco consumption, pollution, and occupational hazards across the globe is anticipated to augment the market during the forecast period. Moreover, easy-to-use and portable devices are likely to boost the growth of the market.
The North America oxygen therapy devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the North America oxygen therapy devices market with respect to market segments based on the product type, application and geographic analysis.
Based on product type, the North America oxygen therapy devices market has been segmented into two major categories: oxygen source equipment and oxygen delivery devices. The oxygen source equipment segment is further categorized into oxygen cylinders, oxygen concentrators and liquid oxygen devices. Moreover, the oxygen delivery devices segment has been sub-segmented into simple oxygen mask, nasal cannula, Venturi mask, non-rebreather mask, bag valve mask, and CPAP mask.
Table of Content
1. Preface
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
2. Executive Summary
2.1. North America Oxygen Therapy Devices: Market Snapshot
2.2. North America Oxygen Therapy Devices Market Share, by Application, 2014 (US$ Mn)
2.3. North America Oxygen Therapy Devices Market Share, by Product Type, 2014 (US$ Mn)
3. Industry Analysis : North America Oxygen Therapy Devices
3.1. Introduction and Market Definition
3.2. Drivers
3.2.1. Rise in incidence of COPD and other respiratory diseases
3.2.2. Increasing patient preference for portable home oxygen therapy equipment
3.3. Restraints
3.3.1. Patient concerns associated with complication of long-term oxygen therapy
3.4. Opportunities
3.4.1. Technological advancements in the field of respiratory care to spur market growth
3.4.2. Increasing government initiatives toward improving respiratory care
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=667882

Wednesday, 4 January 2017

Pipeline Assessment, Market Trend, Technology and Competitive Landscape: Gene Therapy Ophthalmology Insight

ResearchMoz presents this most up-to-date research on "Pipeline Assessment, Market Trend, Technology and Competitive Landscape: Gene Therapy Ophthalmology Insight".

DelveInsight’s Report: Gene Therapy Ophthalmology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Ophthalmology Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety DelveInsight Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

Report facts

DelveInsight Gene Therapy Ophthalmology Report: “Gene Therapy Ophthalmology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape” provides in depth insights into the Ophthalmology gene therapy. It has covered 30+ gene therapies covering 25+ Pharmaceutical companies. Studies are performed for approximately 30+ specific indications under Ophthalmology. The Companies are utilizing 15 different technology platforms which have its own uniqueness and robustness. The Report is also giving insights about the vectors usage in Gene therapy which is approximately 85% for viral vectors, 10% for RNAi therapeutics and 5% for Non Viral vectors. The Report is also giving early winners of the Ophthalmology gene therapy market using DelveInsight proprietary Matrix Model.


Reports Highlights:

  • Global Gene Therapy Overview & Pipeline Insights
  • Trends in gene therapy partnering deals
  • Current Prominent Research Areas and Key Players
  • Companies Targeting Prominent Therapeutic Areas
  • Number of Gene Therapies in Clinical Trials
  • Number of Gene Therapies  by Vectors used
  • Technology and their innovative Companies
  • Early Market Winners for Gene Therapy

Scope

  • A snapshot of the global Gene therapy market scenario, market trends & drivers, manacles of gene therapy.
  • A review of the marketed Gene therapy products and marketing status
  • Coverage of global gene therapies under development across the globe covering territories
  • Competitive landscape of investigational products for key players and key therapy areas.
  • The Gene Therapy report covers the product description, stage of development, licensors & collaborators, Development partner and Technology information
  • The Report also provides the pre-clinical and clinical outcomes of the gene therapies

Reason to Buy

  • Complete Market and Pipeline intelligence and complete understanding over therapeutics development for gene therapy
  • Devise corrective measures for pipeline projects by understanding Therapy area specific gene therapies
  • Developing strategic initiatives to support your gene therapy development activities.
  • Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
  • Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=243501

Tuesday, 3 January 2017

Growth Rate (CAGR) Of Overall NDDS in Cancer Therapy Global Market During 2017-2020

ResearchMoz presents this most up-to-date research on "Growth Rate (CAGR) Of Overall NDDS in Cancer Therapy Global Market During 2017-2020".

This study on novel drug delivery systems (NDDS) in cancer therapy comprises study of technologies such as embolization devices, liquid embolics and nanoparticles that offer unique approaches in cancer remedy. Several embolic agents are used by interventional radiologists for the selective occlusion of arteries supplying blood to tumors. The selection of an embolic agent depends on various factors including size of the vessel to be embolized, desired clinical outcome, duration of the vessel to be occluded, and also the intrinsic properties and behavior of the embolic agent. Nanoparticles as drug delivery systems have emerged as a promising technology to treat patients suffering from various types of cancer. Owing to their small size, nanoparticles exhibit unique physicochemical and biological properties, and thus help in overcoming several limitations such as poor bio-distribution, non-specific drug delivery, low therapeutic indices, and lack of water solubility which are mostly associated with conventional drug delivery.

This report studies the global market for NDDS in cancer therapy encompassing three major technologies: embolization particles, liquid embolics and nanoparticles. Each of these technologies has been analyzed in detail from product analysis, market trends, recent developments, future outlook and opportunities, to the competitive landscape. The report provides market size in terms of USD million for each technology for the period 2012 to 2020, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall NDDS in cancer therapy market and the segments has also been provided in the report for the forecast period 2014 to 2020, considering 2012 and 2013 as the base years. This report includes an elaborate executive summary, which covers a market snapshot representing key findings from the study.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=228495

Geographically, the NDDS in cancer therapy market has been classified into four regions namely, North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR for the forecast period from 2014 to 2020 have also been provided in the report. A detailed qualitative analysis of the major factors determining market dynamics such as drivers, restraints and opportunities, along with the market attractiveness analysis are discussed in the market overview section of the NDDS in cancer therapy market report. A section describing the U.S. and EU regulatory pathways has also been included. The study on NDDS in cancer therapy suggests a list of recommendations for new companies willing to enter the market and for existing companies to accentuate shares, which is likely to help in the decision-making process. ANSOFF matrix analysis has also been provided for the key players in this market. The competitive landscape section has been provided for each technology separately and presents the market revenue share of key players in terms of percentage for the year 2013. The market share analysis of key players involved the study of company product portfolio, sales revenue, and geographical presence along with market developments such as new product launch, brand recall, regulatory approvals, etc.

The global NDDS in cancer therapy market is segmented as follows:

NDDS in Cancer Therapy Market, by Technology
  • Embolization Particles
  • Current Technologies
  • Drug Eluting Beads
  • Others (PVA particles, microspheres, gelatin-based)
  • Emerging Technologies
  • Selective Internal Radiation Therapy (SIRT)
  • TheraSphere
NDDS in Cancer Therapy Market, by Geography
  • North America
  • Embolization Particles
  • Liquid Embolics
  • Nanoparticles
  • Europe
  • Embolization Particles
  • Liquid Embolics
  • Nanoparticles
  • Asia Pacific

Sunday, 11 December 2016

Global Facial Interfaces Market Over The Period 2015-2019

Researchmoz added Most up-to-date research on "Global Facial Interfaces Market Over The Period 2015-2019" to its huge collection of research reports.

Facial interface devices help in treatment using non-invasive ventilation and CPAP therapy. Nasal masks are commonly used for patients suffering from OSA. OSA arises when the soft tissues in the back of the throat relax during sleep and block the airway, causing snoring. Facial interface devices include all types of masks (nasal pillow masks, nasal masks, oral masks, and full-face masks) and humidifiers that provide airflow into the nose or mouth from the CPAP machine.

TechNavio's analysts forecast the Global Facial Interfaces market to grow at a CAGR of 6.80 percent over the period 2014-2019.
 
Covered in this Report

The Global Facial Interfaces market can be segmented into the revenue generated from the following segment such as: Mask Interfaces and Humidifiers.

TechNavio's report, Global Facial Interfaces market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Facial Interfaces market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas 
  • EMEA        
  • APAC

Key Vendors

  • DeVilbiss Healthcare LLC
  • Fisher & Paykel Healthcare
  • Philips Healthcare
  • ResMed

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=246178

Other Prominent Vendors

  • Apex Medical
  • Apria Healthcare
  • Arigmed
  • Armstrong Medical 
  • Bremed
  • Curative Medical 
  • Drager
  • Medtronic
  • Genstar Technologies 
  • Heinen + Lowenstein
  • Hersill
  • Heyer Medical 
  • HOFFRICHTER GmbH
  • InnoMed Technologies
  • Intersurgical 
  • PAHSCO
  • Penlon
  • Sleepnet 
  • Smiths Medical 
  • Sturdy Industrial
  • Weinmann Geräte für Medizin

Market Driver

  • High Prevalence of Sleep Apnea
  • For a full, detailed list, view our report.

Market Challenge

  • Lack of Patient Compliance
  • For a full, detailed list, view our report.

Market Trend

  • Increase in Adoption of Home Diagnostics
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?